Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Microbial-Semiconductor Hybrids Enable Near Infrared-Driven Photosynthetic Hydrogen Production for Tumor-Targeted Immunotherapy.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

Mucin-based injectable hydrogel loaded with Resolvin E1 for rectal mucosal repair after endoscopic submucosal dissection.

Acta biomaterialia·2026

Same author

Coupling Pt Single-Atoms with Amorphous LDH Nanosheets as a High-Efficiency Sonosensitizer for Sonodynamic Immunotherapy.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

Association of atherogenic index of plasma and cardiometabolic index with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018.

Cardiovascular diabetology·2026

Same author

Photothermal-Mediated Topological-Covalent Tissue Adhesives: Synchronizing Robust Integration with Electrically Coupled Biointerfaces.

ACS nano·2025

Same author

Pathologically responsive ZnSrMo-LDH/Cu nanozymes with cascade antioxidant and angiogenic functions for myocardial ischemia-reperfusion treatment.

Theranostics·2025

Search research articles

Related Experiment Video

Updated: Nov 19, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

CCT6A, a novel prognostic biomarker for Ewing sarcoma.

Jie Jiang¹, Chong Liu², Guoyong Xu¹

¹Guangxi Medical University, Department First School of Clinical Medicine.

|February 3, 2021

Summary

Chaperonin containing TCP1 complex 6A (CCT6A) is a potential prognostic biomarker for Ewing sarcoma (ES). High CCT6A expression correlates with poor overall survival and serves as an independent predictor of ES prognosis.

More Related Videos

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Related Experiment Videos

Last Updated: Nov 19, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Area of Science:

Oncology
Molecular Biology
Biomarker Discovery

Background:

Ewing sarcoma (ES) lacks established prognostic biomarkers.
Chaperonin containing TCP1 complex 6A (CCT6A) is implicated in various cancers but its role in ES is unclear.

Purpose of the Study:

Investigate the prognostic role of CCT6A in Ewing sarcoma.
Identify potential biomarkers for ES patient outcomes.

Main Methods:

Bioinformatic analysis of 32 ES specimens (GSE17618 dataset) focusing on gene expression, overall survival (OS), and event-free survival (EFS).
Immunohistochemical analysis to compare CCT6A expression in ES and adjacent tissues.

Main Results:

CCT6A expression was significantly higher in ES tissues than paracancerous tissues.
High CCT6A expression was associated with poor OS (P=.024).
CCT6A, age, and EFS were identified as independent poor prognostic biomarkers in multivariate analysis.

Conclusions:

CCT6A expression levels are strongly associated with Ewing sarcoma prognosis.
CCT6A shows potential as a predictive biomarker for ES outcomes.